Variant report
Variant | nsv873809 |
---|---|
Chromosome Location | chr2:34277979-34317561 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:41)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:7)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:41 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr2:34282589-34282874 | HepG2 | liver: | n/a | n/a |
2 | CEBPB | chr2:34282612-34282876 | A549 | lung: | n/a | n/a |
3 | CEBPB | chr2:34315236-34315504 | HepG2 | liver: | n/a | chr2:34315355-34315366 |
4 | CEBPB | chr2:34292173-34292361 | HepG2 | liver: | n/a | chr2:34292232-34292243 |
5 | CTCF | chr2:34312037-34312114 | GM20000 | blood: | n/a | n/a |
6 | CTCF | chr2:34302050-34302086 | K562 | blood: | n/a | n/a |
7 | E2F4 | chr2:34289805-34290093 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | EBF1 | chr2:34291109-34291397 | GM12878 | blood: | n/a | n/a |
9 | JUN | chr2:34282669-34282870 | HepG2 | liver: | n/a | chr2:34282729-34282742 |
10 | JUN | chr2:34292140-34292339 | HepG2 | liver: | n/a | chr2:34292218-34292231 chr2:34292196-34292209 chr2:34292233-34292246 |
11 | JUND | chr2:34315323-34315423 | HepG2 | liver: | n/a | n/a |
12 | JUND | chr2:34292176-34292349 | HepG2 | liver: | n/a | n/a |
13 | MAFF | chr2:34292229-34292356 | HepG2 | liver: | n/a | n/a |
14 | MAFF | chr2:34284189-34284438 | HepG2 | liver: | n/a | n/a |
15 | MAFK | chr2:34283943-34284451 | HepG2 | liver: | n/a | chr2:34283969-34283980 chr2:34283970-34283981 chr2:34283968-34283982 chr2:34283969-34283980 |
16 | MAFK | chr2:34292222-34292413 | HepG2 | liver: | n/a | chr2:34292274-34292288 chr2:34292267-34292284 |
17 | MAFK | chr2:34304423-34304586 | IMR90 | lung: | n/a | n/a |
18 | MAFK | chr2:34284166-34284362 | HepG2 | liver: | n/a | n/a |
19 | MAFK | chr2:34284151-34284332 | IMR90 | lung: | n/a | n/a |
20 | MAFK | chr2:34292185-34292375 | HepG2 | liver: | n/a | chr2:34292274-34292288 chr2:34292267-34292284 |
21 | MXI1 | chr2:34305896-34305897 | GM12878 | blood: | n/a | n/a |
22 | NFYB | chr2:34291138-34291235 | Hela-S3 | cervix: | n/a | n/a |
23 | POLR2A | chr2:34297673-34297869 | MCF10A-Er-Src | breast: | n/a | n/a |
24 | POLR2A | chr2:34289929-34289994 | A549 | lung: | n/a | n/a |
25 | POLR2A | chr2:34299738-34299780 | Gliobla | brain: | n/a | n/a |
26 | POLR2A | chr2:34312582-34312858 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | POLR2A | chr2:34316607-34316631 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | POLR2A | chr2:34286602-34286721 | ProgFib | skin: | n/a | n/a |
29 | POLR2A | chr2:34282808-34282908 | MCF10A-Er-Src | breast: | n/a | n/a |
30 | RAD21 | chr2:34281579-34281951 | H1-hESC | embryonic stem cell: | n/a | n/a |
31 | RAD21 | chr2:34281688-34281905 | H1-hESC | embryonic stem cell: | n/a | n/a |
32 | RAD21 | chr2:34281581-34281875 | H1-hESC | embryonic stem cell: | n/a | n/a |
33 | SMC3 | chr2:34293718-34293720 | GM12878 | blood: | n/a | n/a |
34 | STAT3 | chr2:34303502-34303702 | MCF10A-Er-Src | breast: | n/a | chr2:34303677-34303700 |
35 | STAT3 | chr2:34315224-34315516 | MCF10A-Er-Src | breast: | n/a | n/a |
36 | STAT3 | chr2:34306651-34306770 | MCF10A-Er-Src | breast: | n/a | n/a |
37 | STAT3 | chr2:34315214-34315544 | MCF10A-Er-Src | breast: | n/a | n/a |
38 | STAT3 | chr2:34315216-34315469 | MCF10A-Er-Src | breast: | n/a | n/a |
39 | TBP | chr2:34306381-34306454 | GM12878 | blood: | n/a | n/a |
40 | USF2 | chr2:34281589-34281595 | HepG2 | liver: | n/a | n/a |
41 | ZNF143 | chr2:34290294-34290318 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
No data |
(count:7 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RASGRP3-1 | chr2:34286086-34286114 | ENSG00000203386 |
2 | lnc-RASGRP3-2 | chr2:34294166-34294617 | XLOC_001422 |
3 | lnc-RASGRP3-2 | chr2:34293281-34293347 | XLOC_001422 |
4 | lnc-RASGRP3-2 | chr2:34292293-34292370 | XLOC_001422 |
5 | lnc-RASGRP3-1 | chr2:34285817-34285994 | ENSG00000203386 |
6 | lnc-RASGRP3-2 | chr2:34288818-34293939 | NONHSAT070031 |
7 | lnc-RASGRP3-2 | chr2:34284362-34284586 | NONHSAT070031 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000237790 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs569593450 | chr2:34284364-34284365 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs538628972 | chr2:34284405-34284406 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs58080018 | chr2:34284412-34284413 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs371096135 | chr2:34284414-34284415 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs552218480 | chr2:34284418-34284419 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs565947105 | chr2:34284496-34284497 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs10192086 | chr2:34284574-34284575 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs574244717 | chr2:34284630-34284631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs536354893 | chr2:34284638-34284639 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs556609420 | chr2:34284642-34284643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs528819821 | chr2:34284666-34284667 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs142254295 | chr2:34284680-34284681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs11302436 | chr2:34284748-34284749 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs34057795 | chr2:34284759-34284760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs540263169 | chr2:34284764-34284765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs558646091 | chr2:34284788-34284789 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs562149568 | chr2:34284802-34284803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs181225547 | chr2:34284820-34284821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs561477371 | chr2:34284835-34284836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs368128813 | chr2:34284842-34284843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs9308945 | chr2:34284852-34284853 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | disease |
22 | rs10179886 | chr2:34284855-34284856 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs532047909 | chr2:34284861-34284862 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs552163859 | chr2:34284920-34284921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs187096760 | chr2:34284939-34284940 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs528371388 | chr2:34284948-34284949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs57496052 | chr2:34284961-34284962 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs569014917 | chr2:34284970-34284971 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs6711736 | chr2:34284984-34284985 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundancedisease |
30 | rs146826653 | chr2:34285009-34285010 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs556409599 | chr2:34285036-34285037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs530477548 | chr2:34285059-34285060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs561853764 | chr2:34285079-34285080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs6729869 | chr2:34285194-34285195 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | disease |
35 | rs573622474 | chr2:34285819-34285820 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs77226994 | chr2:34285855-34285856 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs143438979 | chr2:34285860-34285861 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs17339029 | chr2:34285885-34285886 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs76790837 | chr2:34285910-34285911 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs138044532 | chr2:34285916-34285917 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs143513237 | chr2:34285933-34285934 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs147155033 | chr2:34285980-34285981 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs181667092 | chr2:34285985-34285986 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs138830582 | chr2:34286099-34286100 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs548621894 | chr2:34286101-34286102 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs377683054 | chr2:34286111-34286112 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs146940968 | chr2:34288818-34288819 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs560127272 | chr2:34288822-34288823 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs137913668 | chr2:34288825-34288826 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs11885694 | chr2:34288837-34288838 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 19521722 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21364760 | CNVD |
Wilms tumour | 21544195 | CNVD |
Non-small cell lung cancer | 18927303 | CNVD |
Hereditary gingival fibromatosis | 19633868 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Neurocytoma | 17123091 | CNVD |
Autism | 22495309 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:34284600-34285200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr2:34293000-34293200 | Enhancers | Brain Hippocampus Middle | brain |
3 | chr2:34293000-34293600 | Enhancers | Brain Substantia Nigra | brain |
4 | chr2:34293400-34294800 | Weak transcription | Brain Hippocampus Middle | brain |
5 | chr2:34293600-34295000 | Weak transcription | Brain Substantia Nigra | brain |
6 | chr2:34294200-34294600 | Enhancers | Brain Inferior Temporal Lobe | brain |
7 | chr2:34294200-34295200 | Enhancers | Brain Cingulate Gyrus | brain |
8 | chr2:34294200-34295800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
9 | chr2:34294400-34294800 | Enhancers | Brain Anterior Caudate | brain |
10 | chr2:34294600-34296200 | Weak transcription | Brain Inferior Temporal Lobe | brain |
11 | chr2:34294800-34295000 | Enhancers | Brain Hippocampus Middle | brain |
12 | chr2:34295000-34295400 | Flanking Active TSS | Brain Hippocampus Middle | brain |
13 | chr2:34295000-34295400 | Enhancers | Brain Substantia Nigra | brain |
14 | chr2:34295200-34295400 | Flanking Active TSS | Brain Cingulate Gyrus | brain |
15 | chr2:34295400-34296200 | Weak transcription | Brain Substantia Nigra | brain |
16 | chr2:34295400-34296400 | Active TSS | Brain Cingulate Gyrus | brain |
17 | chr2:34295400-34296400 | Enhancers | Brain Hippocampus Middle | brain |
18 | chr2:34296200-34296600 | Enhancers | Brain Inferior Temporal Lobe | brain |
19 | chr2:34296200-34296600 | ZNF genes & repeats | Brain Substantia Nigra | brain |
20 | chr2:34305800-34306400 | Enhancers | Fetal Intestine Large | intestine |